{
    "Trade/Device Name(s)": [
        "Triage BNP Test"
    ],
    "Submitter Information": "Biosite Incorporated",
    "510(k) Number": "K051787",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021317",
        "K032646"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC"
    ],
    "Summary Letter Date": "September 22, 2005",
    "Summary Letter Received Date": "July 1, 2005",
    "Submission Date": "June 30, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1117"
    ],
    "Regulation Name(s)": [
        "B-type natriuretic peptide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "B-Type Natriuretic Peptide (BNP)"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Triage Meter",
        "Triage MeterPlus"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Triage BNP Test, a rapid fluorescence immunoassay for BNP measurement with Triage Meters to aid diagnosis and risk stratification in heart failure and acute coronary syndromes",
    "Indications for Use Summary": "Aids in diagnosis and assessment of severity of heart failure and risk stratification of patients with acute coronary syndromes and heart failure using quantitative BNP measurement in EDTA whole blood or plasma",
    "fda_folder": "Clinical Chemistry"
}